News & Updates
Filter by Specialty:
Add-on metoprolol of no benefit to high-risk prostate cancer patients
29 Sep 2021
Use of metoprolol among high-risk prostate cancer patients receiving androgen deprivation therapy does not appear to improve oncological outcomes, as shown in a study.
Add-on metoprolol of no benefit to high-risk prostate cancer patients
29 Sep 2021
Inhaled JAK inhibitor cuts exhaled nitric oxide in mild asthma
29 Sep 2021
GDC-0214, an inhaled Janus kinase (JAK) inhibitor, induces dose-dependent reductions in fractional exhaled nitric oxide in patients with mild asthma, a recent study has found.
Inhaled JAK inhibitor cuts exhaled nitric oxide in mild asthma
29 Sep 2021
Palbociclib plus letrozole prolongs survival in Asian patients with advanced breast cancer
29 Sep 2021
byDr Margaret Shi
Palbociclib plus letrozole as first-line treatment improves progression-free survival (PFS) vs placebo plus letrozole in postmenopausal Asian patients with advanced oestrogen receptor (ER)–positive and HER2-negative breast cancer (BC), primary results of the phase III PALOMA-4 study have shown.
